Fior Markets launched a study titled “Global Empty Capsules Market by Type (Gelatin Capsules,Non-gelatin Capsules), Functionality, Application, End User, Region” and Global Forecast 2018-2025.
The global empty capsules market is expected to reach from USD 2,100.05 Million in 2017 to USD 4,200.31 Million by 2025 at a CAGR of 9.10% during the forecast periodfrom 2018-2025. Increasing demand of empty capsules in pharmaceutical, nutraceutical, and cosmetic industries and the growing preference from consumer for capsules over tablets are contributing for the growth of the market.
DOWNLOAD FREE SAMPLE REPORT:https://www.fiormarkets.com/report-detail/375976/request-sample
Gelatin capsules segment is expected to dominate the segment and held largest market share of 54.21% in 2017
The type segment is classified into gelatin capsules and non-gelatin capsules.Gelatin capsulessegment is expected to dominate the segment and held largest market share of 54.21% in 2017. Rapid drug release, uniform mixing, and a barrier to atmospheric oxygen makes them preferred choice for drug shells.
Immediate-release capsules segment is dominating and was valued around USD 1092.92 million in 2017
Functionality segment is divided into immediate-release capsules, sustained-release capsules and delayed-release capsules. Immediate-release capsules segment is dominating and was valued around USD 1,092.92 million in 2017. Widespread use in the manufacturing of antibiotics, antacids, painkillers, inhalators and dietary supplements are major contributing factors. Moreover, these are most commonly prescribed capsules for wide range of diseases and disorders.
The dietary supplements segment is expected to register the highest CAGR of 12.38% during the forecast period
Application segment is bifurcated into antibiotic & antibacterial drugs, dietary supplements, antacid &antiflatulent preparations, antianemic preparations, anti-inflammatory drugs, cardiovascular therapy drugs and other applications. The dietary supplements segment is expected to register the highest CAGR of 12.38% during the forecast period due to increased health awareness and rising affordability in developing countries.
The pharmaceutical industry held the largest share and was valued around USD 798. 83 million in 2017
End user segment is classified into pharmaceutical industry, nutraceutical industry, cosmetic industry and research laboratories. The pharmaceutical industry held the largest share and was valued around USD 798.83 million in 2017. The growth can be attributed to increasing number of drugs launched as capsule formulations and high demand of innovative drug delivery formulations.
BROWSE COMPLETE REPORT AND TABLE OF CONTENTS:https://www.fiormarkets.com/report/global-empty-capsules-market-by-type-gelatin-capsules-375976.html
Regional Segmentation Analysis:
The market is analysed on the basis of five regions namely North America, Europe, Asia Pacific, South America, and Middle East and Africa. NorthAmerica region dominated the marketand accounted for the largest market share of 43.25% in 2017. Rising consumer awareness pertaining to nutraceutical products and health-focused trends in the region are contributing to the growth of the market.
Prominent industry players in the market include ACG Worldwide, Capsugel, Suheung Co., Ltd., Qualicaps, Bright Pharma Caps Inc., Capscanada Corporation, Natural Capsules Limited, Qingdao Yiqing Medicinal Capsules Co., Ltd., Nectar Lifesciences Ltd., Healthcaps India Ltd., Medi-Caps Ltd., Snail Pharma Industry Co. Ltd., Roxlor, Sunil Healthcare Ltd.among others.